License, Commercialization and Option Agreement Sample Contracts

LICENSE, COMMERCIALIZATION AND OPTION AGREEMENT

License, Commercialization and Option Agreement • June 7th, 2018 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York

• Contract Type
  License, Commercialization and Option Agreement
• Filed
  June 7th, 2018
• Company
  Acura Pharmaceuticals, Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This License, Commercialization and Option Agreement (“Agreement”) is made and entered into as of March 16, 2017 (the “Effective Date”) by and between MainPointe Pharmaceuticals, LLC, with offices at 333 East Main Street, Suite 220, Louisville, Kentucky 40202 (“MainPointe”), and Acura Pharmaceuticals, Inc., with offices at 616 N. North Court, Palatine IL 60067 (“Acura”). MainPointe and Acura each are referred to herein as a “Party” and collectively as the “Parties.”